Guideline for the diagnosis and management of myelofibrosis

John T. Reilly, Mary Frances Mcmullin, Philip A. Beer, Nauman Butt, Eibhlean Conneally, Andrew Duncombe, Anthony R. Green, N. George Michaeel, Marie H. Gilleece, Georgina W. Hall, Steven Knapper, Adam Mead, Ruben Mesa, Mallika Sekhar, Bridget Wilkins, Claire N. Harrison

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

The guideline group regarding the diagnosis and management of myelofibrosis was selected to be representative of UK-based medical experts, together with a contribution from a single expert from the USA. MEDLINE and EMBASE were searched systematically for publications in English from 1966 until August 2011 using a variety of key words. The writing group produced the draft guideline, which was subsequently revised by consensus of the members of the General Haematology and Haemato-oncology Task Forces of the British Committee for Standards in Haematology (BCSH). The guideline was then reviewed by a sounding board of UK haematologists, the BCSH and the British Society for Haematology Committee and comments incorporated where appropriate. The criteria used to state levels and grades of evidence are as outlined in the Procedure for Guidelines commissioned by the BCSH; the 'GRADE' system was used to score strength and quality of evidence. The objective of this guideline is to provide healthcare professionals with clear guidance on the investigation and management of primary myelofibrosis, as well as post-polycythaemic myelofibrosis (post-PV MF) and post-thrombocythemic myelofibrosis (post-ET MF) in both adult and paediatric patients.

Original languageEnglish (US)
Pages (from-to)453-471
Number of pages19
JournalBritish Journal of Haematology
Volume158
Issue number4
DOIs
StatePublished - Aug 1 2012
Externally publishedYes

Fingerprint

Primary Myelofibrosis
Hematology
Guidelines
Advisory Committees
MEDLINE
Publications
Pediatrics
Delivery of Health Care

Keywords

  • Myelofibrosis
  • Myeloproliferative disorders
  • Transplantation
  • Treatment

ASJC Scopus subject areas

  • Hematology

Cite this

Reilly, J. T., Mcmullin, M. F., Beer, P. A., Butt, N., Conneally, E., Duncombe, A., ... Harrison, C. N. (2012). Guideline for the diagnosis and management of myelofibrosis. British Journal of Haematology, 158(4), 453-471. https://doi.org/10.1111/j.1365-2141.2012.09179.x

Guideline for the diagnosis and management of myelofibrosis. / Reilly, John T.; Mcmullin, Mary Frances; Beer, Philip A.; Butt, Nauman; Conneally, Eibhlean; Duncombe, Andrew; Green, Anthony R.; Michaeel, N. George; Gilleece, Marie H.; Hall, Georgina W.; Knapper, Steven; Mead, Adam; Mesa, Ruben; Sekhar, Mallika; Wilkins, Bridget; Harrison, Claire N.

In: British Journal of Haematology, Vol. 158, No. 4, 01.08.2012, p. 453-471.

Research output: Contribution to journalArticle

Reilly, JT, Mcmullin, MF, Beer, PA, Butt, N, Conneally, E, Duncombe, A, Green, AR, Michaeel, NG, Gilleece, MH, Hall, GW, Knapper, S, Mead, A, Mesa, R, Sekhar, M, Wilkins, B & Harrison, CN 2012, 'Guideline for the diagnosis and management of myelofibrosis', British Journal of Haematology, vol. 158, no. 4, pp. 453-471. https://doi.org/10.1111/j.1365-2141.2012.09179.x
Reilly JT, Mcmullin MF, Beer PA, Butt N, Conneally E, Duncombe A et al. Guideline for the diagnosis and management of myelofibrosis. British Journal of Haematology. 2012 Aug 1;158(4):453-471. https://doi.org/10.1111/j.1365-2141.2012.09179.x
Reilly, John T. ; Mcmullin, Mary Frances ; Beer, Philip A. ; Butt, Nauman ; Conneally, Eibhlean ; Duncombe, Andrew ; Green, Anthony R. ; Michaeel, N. George ; Gilleece, Marie H. ; Hall, Georgina W. ; Knapper, Steven ; Mead, Adam ; Mesa, Ruben ; Sekhar, Mallika ; Wilkins, Bridget ; Harrison, Claire N. / Guideline for the diagnosis and management of myelofibrosis. In: British Journal of Haematology. 2012 ; Vol. 158, No. 4. pp. 453-471.
@article{446f2821e8e84199a0bb567e5d13bc91,
title = "Guideline for the diagnosis and management of myelofibrosis",
abstract = "The guideline group regarding the diagnosis and management of myelofibrosis was selected to be representative of UK-based medical experts, together with a contribution from a single expert from the USA. MEDLINE and EMBASE were searched systematically for publications in English from 1966 until August 2011 using a variety of key words. The writing group produced the draft guideline, which was subsequently revised by consensus of the members of the General Haematology and Haemato-oncology Task Forces of the British Committee for Standards in Haematology (BCSH). The guideline was then reviewed by a sounding board of UK haematologists, the BCSH and the British Society for Haematology Committee and comments incorporated where appropriate. The criteria used to state levels and grades of evidence are as outlined in the Procedure for Guidelines commissioned by the BCSH; the 'GRADE' system was used to score strength and quality of evidence. The objective of this guideline is to provide healthcare professionals with clear guidance on the investigation and management of primary myelofibrosis, as well as post-polycythaemic myelofibrosis (post-PV MF) and post-thrombocythemic myelofibrosis (post-ET MF) in both adult and paediatric patients.",
keywords = "Myelofibrosis, Myeloproliferative disorders, Transplantation, Treatment",
author = "Reilly, {John T.} and Mcmullin, {Mary Frances} and Beer, {Philip A.} and Nauman Butt and Eibhlean Conneally and Andrew Duncombe and Green, {Anthony R.} and Michaeel, {N. George} and Gilleece, {Marie H.} and Hall, {Georgina W.} and Steven Knapper and Adam Mead and Ruben Mesa and Mallika Sekhar and Bridget Wilkins and Harrison, {Claire N.}",
year = "2012",
month = "8",
day = "1",
doi = "10.1111/j.1365-2141.2012.09179.x",
language = "English (US)",
volume = "158",
pages = "453--471",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Guideline for the diagnosis and management of myelofibrosis

AU - Reilly, John T.

AU - Mcmullin, Mary Frances

AU - Beer, Philip A.

AU - Butt, Nauman

AU - Conneally, Eibhlean

AU - Duncombe, Andrew

AU - Green, Anthony R.

AU - Michaeel, N. George

AU - Gilleece, Marie H.

AU - Hall, Georgina W.

AU - Knapper, Steven

AU - Mead, Adam

AU - Mesa, Ruben

AU - Sekhar, Mallika

AU - Wilkins, Bridget

AU - Harrison, Claire N.

PY - 2012/8/1

Y1 - 2012/8/1

N2 - The guideline group regarding the diagnosis and management of myelofibrosis was selected to be representative of UK-based medical experts, together with a contribution from a single expert from the USA. MEDLINE and EMBASE were searched systematically for publications in English from 1966 until August 2011 using a variety of key words. The writing group produced the draft guideline, which was subsequently revised by consensus of the members of the General Haematology and Haemato-oncology Task Forces of the British Committee for Standards in Haematology (BCSH). The guideline was then reviewed by a sounding board of UK haematologists, the BCSH and the British Society for Haematology Committee and comments incorporated where appropriate. The criteria used to state levels and grades of evidence are as outlined in the Procedure for Guidelines commissioned by the BCSH; the 'GRADE' system was used to score strength and quality of evidence. The objective of this guideline is to provide healthcare professionals with clear guidance on the investigation and management of primary myelofibrosis, as well as post-polycythaemic myelofibrosis (post-PV MF) and post-thrombocythemic myelofibrosis (post-ET MF) in both adult and paediatric patients.

AB - The guideline group regarding the diagnosis and management of myelofibrosis was selected to be representative of UK-based medical experts, together with a contribution from a single expert from the USA. MEDLINE and EMBASE were searched systematically for publications in English from 1966 until August 2011 using a variety of key words. The writing group produced the draft guideline, which was subsequently revised by consensus of the members of the General Haematology and Haemato-oncology Task Forces of the British Committee for Standards in Haematology (BCSH). The guideline was then reviewed by a sounding board of UK haematologists, the BCSH and the British Society for Haematology Committee and comments incorporated where appropriate. The criteria used to state levels and grades of evidence are as outlined in the Procedure for Guidelines commissioned by the BCSH; the 'GRADE' system was used to score strength and quality of evidence. The objective of this guideline is to provide healthcare professionals with clear guidance on the investigation and management of primary myelofibrosis, as well as post-polycythaemic myelofibrosis (post-PV MF) and post-thrombocythemic myelofibrosis (post-ET MF) in both adult and paediatric patients.

KW - Myelofibrosis

KW - Myeloproliferative disorders

KW - Transplantation

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84864300766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864300766&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2012.09179.x

DO - 10.1111/j.1365-2141.2012.09179.x

M3 - Article

C2 - 22651893

AN - SCOPUS:84864300766

VL - 158

SP - 453

EP - 471

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -